Shelton medical transcription firm iMedX Inc. has raised $950,000 in an equity funding round, Mass High Tech reports, citing a regulatory filing.
The financing stemmed from just one unnamed investor, according to the U.S. Securities and Exchange Commission document. A call to iMedX was not immediately returned.
The company, backed by New Canaan-based RFE Investment Partners, makes TurboScribe, a medical transcription software and service combination product.
In January, iMedX raised $2.5 million in an equity funding round.
As of October 2010, the company had acquired at least nine companies in the medical software field since March 2008.